Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
A Florida federal jury has handed down a defense verdict in an Ethicon polypropylene mesh action, finding the device was not defectively designed and did not cause the plaintiffs’ injuries.
A Pennsylvania federal judge has refused to dismiss strict liability claims against Coloplast Corp. in a pelvic mesh case, finding a lack of evidence that the state supreme court would extend comment k immunity to medical devices.
Film actor Chuck Norris and his wife Gena have abandoned their lawsuit accusing the makers of gadolinium-based contrast agents of failing to warn that their products, which are commonly used during MRIs, can cause gadolinium deposition disease.
A Missouri federal judge has allowed the plaintiff in a hip replacement case to amend his petition to allege the correct mechanism of failure in the device, concluding that good cause for amendment was shown.
A Pennsylvania federal judge has reduced an $8 billion punitive damages verdict to $6.8 million in a Risperdal case, agreeing with defendant Janssen Pharmaceuticals Inc. that the award was not proportional to the compensatory damages judgment of $680,000.
Issue #146, January 2020
A federal appellate panel has refused to reinstate a Cymbalta action against Eli Lilly & Co. after the plaintiffs had voluntarily dismissed their claims, ruling that they failed to demonstrate the existence of “extraordinary circumstances justifying the reopening a final judgment.”
A California federal judge has excluded the opinions of plaintiffs’ causation experts in the Viagra/Cialis multidistrict litigation, ruling that they failed to prove an association between use of the drugs and progression of melanoma.
A New Jersey appellate court has upheld the dismissal of an Essure birth control lawsuit, ruling that a majority of the claims are subsumed by the state’s Product Liability Act, and the remaining counts are inadequately pled.
A federal appeals court has upheld a $20 million judgment in a Prolift transvaginal mesh action, holding that under Indiana law, the plaintiffs were not required to present evidence of a cost-effective alternative design to prevail on their design defect claim.
A lawsuit targeting a Smith & Nephew knee replacement system is time-barred because the plaintiff was aware that the device may have caused his injuries by his revision surgery yet failed to file his complaint within two years of that date, an Ohio federal judge has ruled.